Working… Menu

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial (ATCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04332666
Recruitment Status : Not yet recruiting
First Posted : April 3, 2020
Last Update Posted : August 2, 2021
Fonds Erasme pour la Recherche Médicale
Information provided by (Responsible Party):
Erasme University Hospital

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 30, 2022
Estimated Study Completion Date : June 15, 2023